Back to Type 2 Diabetes
NCT04304430
NCT04304430
Who may be able to join
Who might be able to join this trial:
- You have been diagnosed with type 2 diabetes
- You are between 18 and 80 years old
- You have had type 2 diabetes for more than 1 year
- You are starting a medication called dapagliflozin or a DPP-4 inhibitor, taken together with metformin and/or insulin
Who may not be able to join:
- You have type 1 diabetes
- You are under 18 or over 80 years old
- You are currently taking or have previously taken another medication from the same drug family as dapagliflozin, known as SGLT2 inhibitors (confirm with trial site)
- You have kidney disease where your kidneys are not filtering blood well enough — specifically, your kidney filtering rate (eGFR) is below 60 ml/min/1.73m² (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Status
Completed
Phase
Not Applicable
Sponsor
University of Padova
Registry
clinicaltrials_gov
Start date
18 October 2018
Est. completion
26 December 2019
Where this trial is recruiting
🇮🇹 Italy
Primary endpoints
Combined categorized endpoint
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.